MARKETSSTORY 520· JULY 8, 2026

60 Degrees Pharmaceuticals Locks In Rights to Castanospermine for Tick-Borne Disease Research

An exclusive option agreement gives one company the right to negotiate a full license for a technology before any competing party can step in. That is the structure 60 Degrees Pharmaceutica

NDNewsDialy Desk2 MIN READ

SOURCE

globenewswire.com

← PREVIOUS STORY 519Albany contractors who win every job may be undercutting themselves, expert says NEXT STORY 521 →Verdantas acquires American Engineering & Environmental Consultants to deepen AI-driven environmental work

Keep reading

More from the desk.

13MARKETS

Bridgewater trims Amazon as it adds to Shell and PG&E

Big money shifted its holdings last quarter, tilting away from technology and toward energy. Holdings, meaning the shares a fund owns at the end of a reporting period, grew for Shell and PG&E at Bridgewater Associates during the second…

markets1 MIN

22MARKETS

Pershing Square narrows its book to three names: Uber, Brookfield, and Microsoft

Concentration, in portfolio management, means putting most of a fund's capital into a small number of positions rather than spreading it across many names. Pershing Square has organized its

markets1 MIN

40MARKETS

Nintendo shares jump 7% as Pokémon Pokopia tops 5 million sales

Five million copies sold is the number that moved Nintendo's stock. Nintendo shares jumped 7% after Pokémon Pokopia crossed that threshold. The result carries extra weight because rising memory prices

markets1 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk